PRPF18 inhibitors represent a class of chemical compounds specifically designed to interfere with the activity of the pre-mRNA-processing factor 18 (PRPF18), a critical component of the spliceosome machinery. The spliceosome is a complex molecular machinery responsible for removing non-coding introns from precursor mRNA molecules and joining the remaining exons together, thereby ensuring the accurate and functional expression of genes. PRPF18 is a central player in the formation of the spliceosome, and its inhibition disrupts the splicing process, leading to errors in mRNA processing.
These inhibitors target various components of the spliceosome, primarily interacting with the SF3B complex, a subunit of the U2 snRNP (small nuclear ribonucleoprotein) complex. By binding to the SF3B complex, PRPF18 inhibitors interfere with the proper assembly of the spliceosome, thereby hindering its ability to accurately recognize and remove introns from pre-mRNA transcripts. This disruption results in mis-splicing events, where introns are not correctly excised, leading to the production of aberrant mRNA molecules. These defective mRNA transcripts can subsequently encode dysfunctional or truncated proteins or undergo degradation, ultimately impacting cellular functions. The specificity of these inhibitors for PRPF18 and related spliceosome components makes them valuable tools for studying the intricacies of mRNA processing and its role in gene regulation.The development and study of PRPF18 inhibitors have provided valuable insights into the fundamental mechanisms of gene expression and the essential role of the spliceosome in maintaining the integrity of the transcriptome. Researchers continue to explore these chemical compounds to uncover further details about the splicing process and its implications for diseases where mRNA splicing abnormalities may play a role. While their applications remain an ongoing area of investigation, PRPF18 inhibitors serve as indispensable tools for unraveling the intricacies of mRNA splicing in the realm of molecular biology and genetics.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Spliceostatin A | 391611-36-2 | sc-507481 | 1 mg | $1800.00 | ||
Spliceostatin A inhibits PRPF18 by disrupting spliceosome assembly, leading to aberrant RNA splicing and cell growth inhibition. It binds to the SF3B complex. | ||||||
Pladienolide B | 445493-23-2 | sc-391691 sc-391691B sc-391691A sc-391691C sc-391691D sc-391691E | 0.5 mg 10 mg 20 mg 50 mg 100 mg 5 mg | $299.00 $5699.00 $11099.00 $25500.00 $66300.00 $2875.00 | 63 | |
Pladienolide B interferes with PRPF18 function by targeting the SF3B complex, causing splicing errors and cytotoxicity. | ||||||
Herboxidiene | 142861-00-5 | sc-506378 | 1 mg | $1009.00 | ||
Herboxidiene inhibits PRPF18 by targeting SF3B, disrupting splicing and inducing cell cycle arrest. | ||||||
FR901464 | 146478-72-0 | sc-507352 | 5 mg | $1800.00 | ||
FR901464 interferes with PRPF18 function by disrupting spliceosome assembly through interaction with the SF3B complex. | ||||||
SC1 (Pluripotin) | 839707-37-8 | sc-255607 sc-255607A sc-255607B sc-255607C | 1 mg 5 mg 10 mg 25 mg | $167.00 $199.00 $473.00 $779.00 | ||
Pluripotin modulates PRPF18 by targeting spliceosome components, leading to aberrant splicing and growth inhibition. | ||||||
Isoginkgetin | 548-19-6 | sc-507430 | 5 mg | $225.00 | ||
Isoginkgetin interferes with PRPF18 by disrupting spliceosome assembly, causing splice defects and antiproliferative effects. | ||||||